losartan has been researched along with bromodeoxyuridine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, J; Kurokawa, K; Ohno, M; Schwartz, SM; Taguchi, J | 1 |
Liu, SQ | 1 |
Dobrian, AD; Parker, SB; Prewitt, RL; Wade, SS | 1 |
Cook, JL; Re, RN; Zhang, Z | 1 |
Mełeń-Mucha, G; Mucha, SA; Pawlikowski, M; Siejka, A | 1 |
Miyagi, R; Okamoto, H; Sugiyama, K; Yayama, K | 1 |
Mukuda, T; Sugiyama, H | 1 |
Alcalai, R; Eminaga, S; Gorham, JM; Hoffman, SR; Kim, JB; Konno, T; Markwald, RR; Molkentin, JD; Nayor, M; Norris, RA; Schmitt, JP; Seidman, CE; Seidman, JG; Tager, AM; Teekakirikul, P; Toka, O; Wakimoto, H; Wang, L; Wolf, CM | 1 |
Forsten, H; Harjula, A; Immonen, K; Kankuri, E; Kosonen, R; Laine, M; Lakkisto, P; Palojoki, E; Segersvärd, H; Tikkanen, I | 1 |
Furukawa, Y; Hamasaki, S; Kaidoh, T; Koyama, Y; Mukuda, T | 1 |
10 other study(ies) available for losartan and bromodeoxyuridine
Article | Year |
---|---|
Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bromodeoxyuridine; Carotid Artery Diseases; Carotid Artery, Common; Catheterization; Cell Division; Drug Synergism; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Tetrazoles; Tunica Intima; Tunica Media | 1994 |
Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts: relation to eddy blood flow.
Topics: Animals; Antihypertensive Agents; Antimetabolites; Blood Flow Velocity; Bromodeoxyuridine; Cell Division; Culture Techniques; Gene Expression; Hyperplasia; Jugular Veins; Losartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Stress, Mechanical; Tensile Strength; Tunica Intima | 1999 |
AT(1) receptor inhibition does not reduce arterial wall hypertrophy or PDGF-A expression in renal hypertension.
Topics: Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Arteries; Blood Pressure; Bromodeoxyuridine; Capillaries; Carotid Arteries; Hypertension, Renal; Hypertrophy; Losartan; Male; Mesenteric Arteries; Platelet-Derived Growth Factor; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reference Values; RNA, Messenger | 2000 |
In vitro evidence for an intracellular site of angiotensin action.
Topics: Alternative Splicing; Angiotensin Receptor Antagonists; Angiotensinogen; Angiotensins; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bromodeoxyuridine; Carcinoma, Hepatocellular; Cell Division; Clone Cells; Intracellular Fluid; Losartan; Mitotic Index; Mutagenesis, Site-Directed; Oligonucleotides, Antisense; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; Receptors, Angiotensin; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Renin; Sequence Deletion; Tetrazoles; Transfection; Tumor Cells, Cultured | 2001 |
Angiotensins II and IV modulate adrenocortical cell proliferation in ovariectomized rats.
Topics: Adrenal Cortex; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bromodeoxyuridine; Cell Proliferation; Female; Histocytochemistry; Losartan; Models, Animal; Ovariectomy; Rats; Rats, Wistar | 2006 |
Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin B2 Receptor Antagonists; Bromodeoxyuridine; Dose-Response Relationship, Drug; Hepatectomy; Hepatocyte Growth Factor; Hepatocytes; Lisinopril; Liver Regeneration; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Time Factors | 2007 |
An angiotensin II receptor antagonist suppresses running-enhanced hippocampal neurogenesis in rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Proliferation; Dose-Response Relationship, Drug; Drinking; Hippocampus; Losartan; Male; Neurons; Organogenesis; Rats; Rats, Wistar; Running; Time Factors | 2007 |
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.
Topics: Animals; Bromodeoxyuridine; Cardiomyopathy, Hypertrophic; Cell Proliferation; Disease Models, Animal; Fibrosis; Losartan; Mice; Mutation; Myocardium; Myocytes, Cardiac; Sarcomeres; Signal Transduction; Transforming Growth Factor beta | 2010 |
Effects of angiotensin II blockade on cardiomyocyte regeneration after myocardial infarction in rats.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Antimetabolites; Apoptosis; Body Weight; Bromodeoxyuridine; Cardiomegaly; Losartan; Myocardial Infarction; Myocytes, Cardiac; Neovascularization, Physiologic; Proto-Oncogene Proteins c-kit; Rats; Regeneration; Renin; Stem Cells; Ultrasonography; Vascular Endothelial Growth Factor A | 2015 |
Systemic angiotensin II and exercise-induced neurogenesis in adult rat hippocampus.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bromodeoxyuridine; Cell Count; Dentate Gyrus; Doublecortin Domain Proteins; Doublecortin Protein; Immunohistochemistry; Losartan; Male; Microtubule-Associated Proteins; Neurogenesis; Neurons; Neuropeptides; Photomicrography; Rats, Wistar; Receptor, Angiotensin, Type 1; Running | 2014 |